Instead, treatment with both compounds-most prominently SG-8-was associated with reduced phosphorylation levels of EZH2 (Ser21) and its upstream regulator Akt (Ser473), suggesting that modulation of the Akt-EZH2 signaling axis may at least partially contribute to their anti-melanoma activity. Here, AKT1 is linked to melanoma.